News
Arvinas Inc. Feb 20, 2024, 7:00 AM ET –ARV-102 is a novel oral PROTAC® protein degrader designed to cross the blood-brain barrier and target leucine-rich repeat kinase 2(LRRK2) – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback